Lhasa Limited shared knowledge shared progress
Loading...
PublicationsJump to results
Authors
Publication Type
Publication Year
Related event
Related Products
Reset
TitlePublishedTypeProducts
Expert Systems - The Use of Expert Systems in Drug Design-Toxicity and MetabolismJanuary 2012Derek NexusMeteor Nexus
Explora, A New Language to Define Powerful Structural Queries.pdfJune 2011pdf fileDerek Nexus
Extrapolation of in vitro mutagenicity alerts to the in vivo endpoint in Derek NexusAugust 2017pdf fileDerek Nexus
Food for thought - A toxicology ontology roadmapDecember 2012Derek Nexus
Generics Perspective: Success Strategies for Genotoxic Impurity Identification, Assessment and ControlJune 2015pdf fileDerek NexusSarah Nexus
Getting under the skin of an in silico approach to predicting dermal sensitisationAugust 2017pdf fileDerek Nexus
Giving Confidence for in silico GTI Assessment.pdfJune 2013pdf fileDerek Nexus
How important is expert review when measuring EC3 predictions in Derek Nexus?: Alkyl halides - a case studyMarch 2017pdf fileDerek Nexus
How to discover new structural alerts and recognise new secondary molecular attributes that modulate alert effectivenessOctober 2016pdf fileDerek Nexus
ICH M7 - Have you got it covered?March 2015Derek NexusMirabilisSarah NexusVitic NexusZeneth
ICH M7 - Worked Examples using the new Nexus workflowMarch 2016pdf fileDerek NexusSarah Nexus
ICH M7 BrochureMarch 2018pdf fileDerek NexusSarah NexusVitic NexusZeneth
ICH M7 Classification and the involvement of (Q)SAR methodsOctober 2016pdf fileDerek NexusSarah Nexus
ICH M7 Classification WorkflowMarch 2017pdf fileDerek NexusSarah Nexus
ICH M7 How Lhasa can support you.pdfMarch 2014pdf fileDerek Nexus
ICH M7 Workflow.pdfNovember 2015pdf fileDerek NexusSarah NexusVitic Nexus
Identification of Adverse Outcome Pathways for the Nephrotoxicity of Nucleoside and Nucleotide Anti-Viral DrugsMarch 2014pdf fileDerek Nexus
Implementation of ICH M7 Recommended (Q)SAR AnalysesMarch 2016pdf fileDerek NexusSarah NexusVitic NexusZeneth
Improvements to in silico mutagenicity predictivity of aromatic amines with access to proprietary dataMarch 2016pdf fileDerek Nexus
Improvements to in silico predictivity after access to proprietary dataApril 2016Derek Nexus
Improvements to In Silico Skin Sensitization Predictivity After Access to Proprietary DataMarch 2016pdf fileDerek Nexus
In Silico Analysis Of A Human Cardiac Adverse Effects Data Set.pdfJune 2010pdf fileDerek Nexus
In silico approaches to knowledge and data sharingOctober 2015pdf fileDerek NexusSarah Nexus
In silico prediction of the skin sensitisation potential of non-quinonoid Michael acceptors: new reactivity assessments and evidence based precursor selectionSeptember 2017pdf fileDerek Nexus
In Silico Strategies to Assess Potentially Mutagenic Impurities Under ICH M7March 2017pdf fileDerek NexusSarah NexusMirabilisVitic Nexus

© 2018 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.